Cancer
fromNews Center
3 days agoTranscription Factor Drives Chemotherapy Resistance in Ovarian Cancer - News Center
SOX9-driven epigenetic reprogramming promotes chemotherapy resistance in ovarian cancer cells, offering a targetable mechanism to improve treatment outcomes.